Annual Meeting 2006: The biotechnology and pharmaceutical industry faces a unique and daunting set of statutory and regulatory issues, including, but not limited to, the handling and disposal of radioactive materials, employee health & safety procedures involving unique and exotic compounds, NRC licensing, and good laboratory practices. Smaller companies in this industry also face unique challenges such as developing sound EH&S programs in-house as well as negotiating leases with landlords unfamiliar with biotech research operations. Our panelists will explore the legal foundations of these issues, discuss the regulatory framework in which their respective companies operate, and lay down a suggested path for both large and small companies in this industry to follow.